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Abstract
Background: Elloramycin is an anthracycline-like antitumor
drug related to tetracenomycin C which is produced by
Streptomyces olivaceus Tu«2353. Structurally is a tetracyclic
aromatic polyketide derived from the condensation of 10 acetate
units. Its chromophoric aglycon is glycosylated with a permethy-
lated L-rhamnose moiety at the C-8 hydroxy group. Only limited
information is available about the genes involved in the biosyn-
thesis of elloramycin. From a library of chromosomal DNA from
S. olivaceus, a cosmid (16F4) was isolated that contains part of the
elloramycin gene cluster and when expressed in Streptomyces
lividans resulted in the production of a non-glycosylated inter-
mediate in elloramycin biosynthesis, 8-demethyl-tetracenomycin C
(8-DMTC).
Results : The expression of cosmid 16F4 in several producers of
glycosylated antibiotics has been shown to produce tetracenomy-
cin derivatives containing different 6-deoxysugars. Different
experimental approaches showed that the glycosyltransferase gene
involved in these glycosylation events was located in 16F4. Using
degenerated oligoprimers derived from conserved amino acid
sequences in glycosyltransferases, the gene encoding this sugar
flexible glycosyltransferase (elmGT) has been identified. After
expression of elmGT in Streptomyces albus under the control of the
erythromycin resistance promoter, ermEp, it was shown that elmG
can transfer different monosaccharides (both L- and D-sugars) and
a disaccharide to 8-DMTC. Formation of a diolivosyl derivative in
the mithramycin producer Streptomyces argillaceus was found to
require the cooperative action of two mithramycin glycosyltrans-
ferases (MtmGI and MtmGII) responsible for the formation of the
diolivosyl disaccharide, which is then transferred by ElmGT to
8-DMTC.
Conclusions: The ElmGT glycosyltransferase from S. olivaceus
Tu«2353 can transfer different sugars into the aglycon 8-DMTC. In
addition to its natural sugar substrate L-rhamnose, ElmGT can
transfer several L- and D-sugars and also a diolivosyl disaccharide
into the aglycon 8-DMTC. ElmGT is an example of sugar flexible
glycosyltransferase and can represent an important tool for
combinatorial biosynthesis. ß 2001 Elsevier Science Ltd. All
rights reserved.
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1. Introduction
A number of bioactive compounds contain sugars at-
tached to their aglycons. Usually, glycosylation occurs as
late steps in biosynthesis and the addition of the respective
sugars is important and, in many cases, essential for bio-
logical activity of the compounds. Most of these sugars
belong to the large family of the 6-deoxyhexoses (6-
DOH) which form part of a great number of natural prod-
ucts and at least 80 di¡erent 6-DOH have been identi¢ed
in di¡erent metabolites [1^3]. In the last years, a number
of deoxysugar biosynthetic pathways from antibiotic-pro-
ducing organisms are increasingly being reported [3], pro-
viding the information needed to design new gene combi-
nations directing the biosynthesis of di¡erent 6-DOHs. In
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addition, several glycosyltransferase genes have been
cloned and characterized [4^13], supplying the necessary
tools for the potential generation of new glycosylated bio-
active compounds.
Elloramycin is an anthracycline-like antitumor drug
produced by Streptomyces olivaceus Tu«2353 [14]. It is ac-
tive against Gram-positive bacteria and also exhibits anti-
tumor activity [15]. Structurally, elloramycin belongs to
the large and important family of the aromatic polyketides
[16]. Its aglycon closely resembles tetracenomycin C, but
has an additional C-12a-O-methyl group and, in contrast
to tetracenomycin C, is glycosylated with a permethylated
L-rhamnose residue at the C-8 hydroxyl group (Fig. 1A).
Not too much information exists about genes involved in
elloramycin biosynthesis. Using a cosmid library of chro-
mosomal DNA from S. olivaceus, several overlapping cos-
mid clones were isolated by probing this cosmid library
with two polyketide synthase genes of the tetracenomycin
cluster (tcmK and tcmL) [17]. Two positive cosmid clones
(16F4 and 4F5) were characterized in some detail. Di¡er-
ent tetracenomycin C genes were used as probes to detect
the presence of homologous elloramycin genes in these
cosmids (Fig. 1B). The conclusion was that basically the
sequential order of the tcm and elm genes appeared to be
very similar [17]. Expression of 16F4 in Streptomyces livi-
dans TK64 resulted in the production of several putative
intermediates in elloramycin biosynthesis, 8-demethyl-tet-
racenomycin C (8-DMTC; Fig. 1A), a non-glycosylated
intermediate, being the major compound. It was therefore
assumed that 16F4 should contain all genes necessary for
the biosynthesis of the polyketide moiety of elloramycin
and should probably lack some of the genes required for
L-rhamnose biosynthesis or its transfer to the aglycon.
Interestingly, 16F4 has been shown to be a good genet-
ical tool for the generation of novel compounds by com-
binatorial biosynthesis. Novel hybrid compounds were ob-
tained after introducing 16F4 into di¡erent producer
strains. These were hybrid compounds between urdamycin
and elloramycin [18], mithramycin and elloramycin [19]
and oleandomycin and elloramycin [20]. All these com-
pounds have a common feature: they share the aglycon
(8-DMTC encoded by 16F4) and contain di¡erent sugar
moieties synthesized by the host strain. Here we report
experimental evidence demonstrating the presence of a
sugar £exible glycosyltransferase in 16F4, its cloning and
expression and evidence of the sugar £exible capability of
this enzyme.
2. Results and discussion
2.1. cos16F4 contains a gene encoding a glycosyltransferase
responsible for the formation of glycosylated
tetracenomycins
The formation of di¡erent glycosylated tetracenomycins
after expression of 16F4 into several producer organisms
raised a question about the genetic location of the gene
encoding the glycosyltransferase responsible for sugar
transfer into the aglycon: would it be coded by 16F4 or
would it be a glycosyltransferase present in the transfor-
mation host? To discern between these two possibilities we
Fig. 1. (A) Structures of elloramycin, 8-DMTC and mithramycin. (B) Schematic representation of the restriction map of cosmid 16F4: the shadowed
bar indicates the region that has been shown to hybridize with the tcmAGNPKLM genes of the tetracenomycin C gene cluster [17]. The black bar shows
the location of the fragment hybridizing against the 350 bp PCR probe. The black triangle represents the ermEp. B, BamHI; M, MboI ; P, PstI; S, SalI.
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carried out several experiments using several hosts with
di¡erent genetic backgrounds (Table 1). When 16F4 was
transformed into the mithramycin producer, Streptomyces
argillaceus, four compounds were produced by the re-
combinant strain: the elloramycin aglycon 8-DMTC
and three glycosylated derivatives. Two of them contained
a D-olivose or a D-mycarose moiety attached to the agly-
con, 8-demethyl-8-L-D-olivosyl-tetracenomycin C (DOLV-
TCM) and 8-demethyl-8-L-D-mycarosyl-tetracenomycin C
(DMYC-TCM). The third one contained a diolivosyl di-
saccharide attached to the aglycon, 8-demethyl-8-L-D-dioli-
vosyl-3P-1Q-D-L-tetracenomycin C (DDIOLV-TCM). The
puri¢cation and structural elucidation of these compounds
was previously carried out [19] and from that moment it
was possible to identify these compounds in the di¡erent
recombinant strains by comparison of their high perfor-
mance liquid chromatography (HPLC) mobility and ab-
sorption spectra with pure samples.
To verify if a glycosyltransferase from the host strain
was responsible for the sugar transfer, S. argillaceus wild
type strain was transformed with pWHM1026vtcmO. This
plasmid contains the entire tetracenomycin C gene cluster
with the exception of the tcmO gene that codes for a 8-O-
methyltransferase and therefore directs the production of
8-DMTC. The resultant recombinant strain produced
8-DMTC but none of the glycosylated compounds were
formed. Since in this strain the aglycon was produced and
the sugars to be transferred (D-olivose and D-mycarose)
were synthesized by the host strain, the absence of glyco-
sylated tetracenomycins was a clear indication that the
glycosyltransferase was absent from this recombinant
strain and therefore from the S. argillaceus host genome.
A similar result and conclusion was obtained by feeding
S. argillaceus wild type strain with 8-DMTC since no gly-
cosylated tetracenomycin derivatives were generated.
These results strongly suggested that the glycosyltransfer-
ase should be coded by 16F4.
Another strong indication that 16F4 harbors the glyco-
syltransferase gene came from experiments in which 16F4
was used to transform the S. argillaceus M3vMG mutant.
This is a mithramycin non-producing mutant in which a
DNA fragment has been deleted by gene replacement
eliminating a region containing four mithramycin glyco-
syltransferases (mtmGI, mtmGII, mtmGIII and mtmGIV)
and two methyltransferases (mtmMI and mtmMII) from
the chromosome [21]. When 16F4 was transformed into
the M3vMG mutant, three of the four compounds were
produced (8-DMTC, DOLV-TCM and DMYC-TCM),
DDIOLV-TCM not being detected. This demonstrates
that generation of the monoglycosylated derivatives is
not dependent upon the activity of any mithramycin gly-
cosyltransferase (since none of them are present in this
mutant) but it requires the presence of a glycosyltransfer-
ase gene in 16F4. Interestingly, DDIOLV-TCM was only
formed in S. argillaceus wild type strain but not in this
mutant (see below for further experiments and discussion).
The ¢nal and de¢nitive evidence demonstrating that the
glycosyltransferase is present in 16F4 and not in the host
strains came from another experiment in which 16F4 was
transformed into S. lividans harboring pFLOS. This is a
plasmid that contains several genes of the mithramycin
gene cluster (mtmD, mtmE, mtmC, mtmU, mtmV, mtmT3
and mtmW) most of which were supposed to be involved
in sugar biosynthesis. The recombinant strain S. lividans
FLOS/16F4 directed the production of two of the glyco-
sylated compounds, but not DDIOLV-TCM. Since no mi-
thramycin glycosyltransferases are present in this host
strain, this experiment was a clear and de¢nitive proof
that the glycosyltransferase is encoded by 16F4. The con-
clusion of all these experiments was that 16F4 must con-
tain a gene encoding a glycosyltransferase that could
transfer individually D-olivose and D-mycarose or a dioli-
vosyl disaccharide to the 8-DMTC aglycon, providing this
disaccharide is previously synthesized by the mithramycin
glycosyltransferases (see below).
2.2. Cloning of the elmGT glycosyltransferase gene
To clone the elloramycin glycosyltransferase gene from
16F4 we initially used a hybridization approach. The
Table 1
Biosynthesis of glycosylated tetracenomycins by di¡erent recombinant strains
Host Plasmid/cosmid constructs Products
8-DMTC DOLV-TCM DMYC-TCM DDIOLV-TCM
S. argillaceus wt 16F4 + + + +
S. argillaceus wt pWHM1026vtcmO + 3 3 3
S. argillaceus M3vMG 16F4 + + + 3
S. lividans TK21 16F4 + 3 3 3
S. lividans TK21 16F4+pFLOS + + + 3
S. argillaceus M3G1 16F4 + + + 3
S. argillaceus M3G2 16F4 + + + 3
S. argillaceus M3vMG pGB15+pEPG1 + + + 3
S. argillaceus M3vMG pGB15+pEPG2 + + + 3
S. argillaceus M3vMG pGB15+pEPG12 + + + +
8-DMTC, 8-demethyl-tetracenomycin C; DOLV-TCM, 8-demethyl-8-L-D-olivosyl-tetracenomycin C; DMYC-TCM, 8-demethyl-8-L-D-mycarosyl-tetrace-
nomycin C; DDIOLV-TCM, 8-demethyl-8-L-D-diolivosyl-3P-1Q-D-L-tetracenomycin C.
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Fig. 2. Nucleotide sequence of the 1850 bp DNA region sequenced containing elmGT. The complete nucleotide sequence of the fragment is shown with
the deduced amino acid sequence of elmGT in a single letter code. The sequence has been deposited in GenBank under the accession number
AJ300305.
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mtmGI glycosyltransferase gene from the mithramycin
cluster was used as a probe against BamHI-digested cos-
mid 16F4 DNA; however, no clear hybridization signal
was observed in spite of using di¡erent stringency condi-
tions. We therefore used another approach by using poly-
merase chain reaction (PCR) and two oligoprimers derived
from consensus amino acid sequences obtained after com-
parison of known glycosyltransferases from antibiotic-pro-
ducing microorganisms (Fig. 3A). Using this pair of oli-
goprimers and 16F4 DNA as template, a 350 bp PCR
fragment was ampli¢ed. Preliminary partial sequence of
this fragment and comparison of its deduced amino acid
sequence with proteins in databases showed that it could
code for an internal region of a glycosyltransferase. This
PCR fragment was then used as probe to locate the gly-
cosyltransferase gene within 16F4 and found to hybridize
within a 9.5 kb BamHI fragment located at the right-hand-
side of 16F4 (Fig. 1B). Further subcloning and Southern
analysis reduced the hybridizing region to a minimal re-
gion of 1.5 kb SalI fragment (Fig. 1B). A region of 1.85 kb
was sequenced and the nucleotide sequence (Fig. 2) ana-
lyzed for the presence of potential coding regions using the
CODONPREFERENCE program [22]. The presence of
an open reading frame (ORF) was observed (named
elmGT) that started at an ATG codon and ended at a
TGA codon. This ORF comprised 1152 nucleotides and
coded for a polypeptide of 384 amino acids and had an
estimated Mr of 39 674 Da. This ORF showed the char-
acteristic high GC content of Streptomyces genes and the
bias in the third codon position characteristic of the genes
of this genus. Comparison of the deduced product of
elmGT with proteins in databases, showed clear similar-
ities with di¡erent glycosyltransferases. The highest scores
were with SnogD, a glycosyltransferase from Streptomyces
nogalater involved in nogalamycin biosynthesis (39.5%
identity) [23], UrdGT1b and UrdGT1c, glycosyltransfer-
ases from Streptomyces fradiae involved in urdamycin bio-
synthesis (39 and 38% identity, respectively) [13], IroB a
glycosyltransferase from Salmonella typhi (34% identity)
[23], OleG2 a glycosyltransferase from Streptomyces anti-
bioticus involved in oleandomycin biosynthesis (34% iden-
tity) [8], MtmGII a glycosyltransferase from S. argillaceus
involved in mithramycin biosynthesis (34% identity) [7]
and LanGT2 a glycosyltransferase from Streptomyces cy-
anogenus involved in landomycin biosynthesis (30% iden-
tity) [11]. A comparative dendrogram showing similarities
between the ElmGT and other antibiotic glycosyltransfer-
ases is shown in Fig. 3B.
2.3. Con¢rmation of the ElmGT sugar £exibility
Once the elloramycin glycosyltransferase gene was iden-
ti¢ed, it was expressed in di¡erent hosts for in vivo assay
of its capability to transfer several dTDP-sugars into the
elloramycin aglycon. The elmGT gene was subcloned
under the control of the erythromycin resistance promoter
ermEp in the multicopy plasmid vector pIAGO (generat-
ing pGB15) and then together with the promoter in the
integrative plasmid vector pKC796 (generating pGB16).
After transforming protoplasts of Streptomyces albus
with pGB16, clones in which the plasmid was integrated
into the chromosome through the att integration site were
identi¢ed by resistance to apramycin and veri¢ed by
Southern analysis. The resultant recombinant strain
(GB16) was then transformed independently with several
plasmid constructs that direct the biosynthesis of di¡erent
dTDP-L-sugars (Table 2). These constructs (pRHAM,
pOLE and pOLV) contain di¡erent combinations of ole-
androse biosynthetic genes from S. antibioticus, an olean-
domycin producer, and direct the biosynthesis of dTDP-L-
Fig. 2 (continued).
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Fig. 3. (A) Alignment of the deduced amino acid sequences of di¡erent glycosyltransferases around the conserved regions chosen for designing the two
oligoprimers for PCR ampli¢cation. FP and RP indicate the amino acid regions selected for the forward and reverse primer, respectively. IroB, glycosyl-
transferase from S. typhi [24] ; SnogD, glycosyltransferase from S. nogalater [23]; UrdGT1b and UrdGT1c, glycosyltransferases from S. fradiae [3] ;
OleG2, glycosyltransferase from S. antibioticus [8] ; LanGT2, glycosyltransferase from S. cyanogenus [11]; MtmGII, glycosyltransferase from S. argilla-
ceus [7]. (B) Dendrogram showing the similarities among di¡erent glycosyltransferases : all glycosyltransferases shown are involved in antibiotic biosyn-
thesis in producer organisms, with the exception of IroB.
Table 2
Biotransformation experiments to assay in vivo the activity of the ElmG glycosyltransferase in S. albus using di¡erent constructs directing the biosyn-
thesis of several 6-deoxysugars
The black triangle indicates the position and orientation of the erythromycin resistance promoter.
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rhamnose, dTDP-L-olivose and dTDP-L-oleandrose, re-
spectively [20,25]. Transformants were selected for resis-
tance to thiostrepton. The double recombinant strains har-
boring the elmGT gene integrated into the chromosome
and the replicative plasmids directing the biosynthesis of
di¡erent 6-DOH were used for biotransformation experi-
ments. They were incubated for 24 h in liquid medium and
then 8-DMTC was added (100 Wg/ml ¢nal concentration).
After 2 days of further incubation, the bioconversion of 8-
DMTC to glycosylated derivatives was monitored (thin
layer chromatography (TLC) and HPLC). In the presence
of pRHAM, bioconversion of 8-DMTC was a very e⁄-
cient process. Since it was previously shown [20] that
pRHAM directs the biosynthesis of dTDP-L-rhamnose, it
was assumed that the bioconverted product was L-rham-
nosyl-tetracenomycin C. The product was puri¢ed and
nuclear magnetic resonance analysis con¢rmed this pre-
sumption. Strains harboring either pOLV or pOLE gave
a good bioconversion of 8-DMTC into the same com-
pound, L-olivosyl-tetracenomycin C (LOLV-TCM), as it
was con¢rmed by running the bioconversion products in
parallel with pure LOLV-TCM as standard. L-Olivose has
been proposed to be an intermediate in L-oleandrose bio-
synthesis in S. antibioticus [25]. These experiments con¢rm
that ElmGT can recognize L-2,6-deoxysugars (i.e. L-oli-
vose) in addition to its natural sugar substrate, an L-6-
deoxysugar like L-rhamnose. The elmGT gene was also
expressed (in pGB15) in the S. argillaceus mutant
M3vMG in order to verify its capability to transfer D-
sugars. Transformants were selected by their resistance
to thiostrepton and used in biotransformation experiments
with 8-DMTC. Formation of the monoglycosylated tetra-
cenomycin derivatives (DOLV-TCM and DMYC-TCM)
was observed but the presence of the diglycosylated deriv-
ative (DDIOLV-TCM) was not detected, suggesting the
involvement of some mithramycin glycosyltransferases in
the formation of the disaccharide derivative.
2.4. Formation of DDIOLV-TCM requires the cooperation
of two mithramycin glycosyltransferases and the
elloramycin glycosyltransferase, ElmGT
As shown above, the diglycosylated tetracenomycin
DDIOLV-TCMC was not produced in S. argillaceus mu-
tant M3vMG in which all the mithramycin glycosyltrans-
ferases were absent. This cannot be explained by the ab-
sence of an intracellular pool of dTDP-D-olivose in this
mutant since the monoglycosylated derivative DOLV-
TCMC was still produced. This raised an interesting ques-
tion about how the diolivosyl disaccharide was formed
and transferred. From the above shown results, it can be
concluded that ElmGT plus some mithramycin glycosyl-
transferases are required for the biosynthesis of DDIOLV-
TCM. Mithramycin contains a diolivosyl disaccharide at-
tached to the C-6 position of the mithramycinone aglycon.
It has been proposed that during mithramycin biosynthesis
Fig. 4. Structures of 8-DMTC and 6-DOH (substituted at R) forming part of novel glycosylated tetracenomycin derivatives generated with the particip-
ation of the ElmGT glycosyltransferase.
CHBIOL 75 5-4-01
Research Paper Sugar £exible glycosyltransferase G. Blanco et al. 259
this disaccharide is not formed by a sequential addition of
the two D-olivose moieties but rather a diolivosyl disac-
charide is ¢rstly formed and then transferred [7]. The
mtmGI and mtmGII gene products would be responsible
for this synthesis and incorporation, although it is not yet
clear which one was responsible for the formation of the
disaccharide and its transfer [7]. Therefore, we thought
that the biosynthesis of DDIOLV-TCM should require
either one or both MtmGI and MtmGII glycosyltransfer-
ases for the formation of the diolivosyl disaccharide and
ElmGT to transfer the disaccharide. To test this hypoth-
esis, 16F4 was used to transform protoplasts of two S.
argillaceus mutants (M3G1 and M3G2 mutants), in which
either mtmGI or mtmGII genes were independently inacti-
vated, respectively [7]. Analysis of the products synthe-
sized by these recombinant strains showed that only the
monoglycosylated tetracenomycins were produced, sug-
gesting that the presence of both mithramycin glycosyl-
transferases was required for the formation of DDIOLV-
TCM. Further con¢rmation was obtained when S. argilla-
ceus M3vMG containing pGB15 (and therefore expressing
elmGT) was independently transformed with pEM4A
(control), pEPG1 (expressing mtmGI), pEPG2 (expressing
mtmGII) or pEPG12 (expressing both mtmGI and
mtmGII). Selected clones from these transformations
were then incubated in the presence of 8-DMTC. Analysis
of the biotransformation products after 2 days of incuba-
tion showed that no DDIOLV-TCM formation was ob-
served with clones individually expressing mtmGI or
mtmGII but DDIOLV-TCM was detected in the culture
supernatant of clones that simultaneously expressed both
mithramycin glycosyltransferases. From these results three
main conclusions can be drawn: (i) addition of the dioli-
vosyl disaccharide does not occur by sequential incorpo-
ration of the two sugars but rather by the direct transfer of
the disaccharide; (ii) the MtmGI and MtmGII glycosyl-
transferases are responsible for the formation of the dio-
livosyl disaccharide and (iii) the disaccharide is then trans-
ferred by ElmGT to 8-DMTC.
2.5. Sugar £exible glycosyltransferases for generating new
bioactive compounds
For the generation of novel glycosylated compounds by
combinatorial biosynthesis, a certain degree of substrate
£exibility of the glycosyltransferases is required. Recent
studies by di¡erent laboratories have shown that some
glycosyltransferases from di¡erent antibiotic biosynthetic
pathways have relaxed substrate speci¢city. Glycosyltrans-
ferases involved in sugar transfer during the biosynthesis
of glycopeptide antibiotics have been shown to transfer
sugars to di¡erent, but structurally related, heptapeptides
[26]. In addition, some macrolide glycosyltransferases can
transfer di¡erent sugars into an aglycon [10,25,27^29]. The
ElmGT we reported here adds a new and important ex-
ample of sugar £exibility to antibiotic glycosyltransferases.
ElmGT apparently shows a broader £exibility for the sug-
ar substrate than any other glycosyltransferase from anti-
biotic pathways so far described. ElmGT is capable of
transferring to its natural substrate aglycon (8-DMTC)
di¡erent L-DOHs as its natural sugar substrate, L-rham-
nose (6-DOH), L-olivose (2,6-DOH) and L-rhodinose
(2,3,6-DOH) (Fig. 4). In addition, it can also transfer
some D-sugars as D-olivose and D-mycarose (2,6-DOHs)
and it can even transfer a D-olivose disaccharide. Interest-
ingly, for the biosynthesis of this disaccharide the joint
action of two mithramycin glycosyltransferases (MtmGI
and MtmGII) is required. As far as we know this is the
¢rst report on antibiotic biosynthetic pathways in which a
collaborative action of two glycosylating enzymes for the
formation of a disaccharide has been stated.
3. Signi¢cance
The generation of novel bioactive compounds with an
altered glycosylation pattern requires substrate £exibility
of the glycosyltransferases. The rhamnosyl glycosyltrans-
ferase ElmGT from S. olivaceus, and other £exible glyco-
syltransferases, constitute powerful tools for producing
novel hybrid glycoside antibiotics through the incorpora-
tion of di¡erent sugar moieties into the corresponding
aglycons. This will require an understanding of which ami-
no acid residues/regions are involved in the recognition of
the cofactor (dTDP-activated 6-DOH) and the substrate
(aglycon) to act on speci¢c amino acid residues in order to
improve sugar £exibility.
4. Materials and methods
4.1. Bacterial strains, culture conditions and vectors
S. olivaceus Tu«2353, the elloramycin producer, was used as the
source of chromosomal DNA. The following wild type Strepto-
myces strains were used as transformation hosts: S. albus G, S.
lividans TK21 and S. argillaceus ATCC 12956. In addition, sev-
eral mithramycin non-producing mutants were also used as trans-
formation hosts: S. argillaceus M3vMG [21] and S. argillaceus
M3G1 and M3G2 [7]. Growth was carried out on trypticase soya
broth (TSB; Oxoid) or R5A medium [7]. For sporulation, growth
was for 7 days at 30‡C on agar plates containing A medium [7].
Protoplast formation and transformation were carried out using
standard procedures [30] with some minor modi¢cations for S.
argillaceus [31]. Escherichia coli XL1-Blue [32] was used as a host
for subcloning and was grown at 37‡C in TSB medium (Oxoid).
The bifunctional (Streptomyces^E. coli) replicative plasmid vec-
tors pIAGO [25], pEM4A (this paper) and the integrative vector
pKC796 [33] were used for gene expression in Streptomyces.
pEM4A is a pEM4 derivative [34] containing the apramycin re-
sistance cassette subcloned as a blunt-ended HindIII^BamHI
fragment from pEFBA [35] into the unique EcoRV site located
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within the thiostrepton resistance gene. Consequently, pEM4A
confers resistance to apramycin and not to thiostrepton. When
plasmid-containing clones were grown, the medium was supple-
mented with the appropriate antibiotics : 5 or 50 Wg/ml thiostrep-
ton for liquid or solid cultures, respectively, 100 Wg/ml for ampi-
cillin, 2.5 or 25 Wg/ml apramycin for liquid or solid cultures,
respectively, or 20 Wg/ml tobramycin.
4.2. DNA manipulation and sequencing
Plasmid DNA preparations, restriction endonuclease diges-
tions, alkaline phosphatase treatments, ligations and other
DNA manipulations were performed according to standard pro-
cedures for E. coli [36] and for Streptomyces [30]. Sequencing was
performed on double-stranded DNA templates in pUC18 by us-
ing the dideoxynucleotide chain-termination method [37] and the
Cy5 AutoCycle Sequencing Kit (Pharmacia Biotech). Both DNA
strands were sequenced with primers supplied in the kits or with
internal oligoprimers (17-mer) using an ALF-express automatic
DNA sequencer (Pharmacia). Computer-aided data base search-
ing and sequence analyses were carried out using the University
of Wisconsin Genetics Computer Group programs package
(UWGCG) [22] and the BLAST program [38].
4.3. PCR ampli¢cation
Degenerated oligoprimers were designed to try to locate the
presence of the elmGT glycosyltransferase gene in cosmid 16F4.
They were derived from conserved amino acid sequences present
in a number of di¡erent antibiotic glycosyltransferases (see Fig.
3A). These oligoprimers were used to attempt PCR ampli¢cation
using as template cosmid 16F4 DNA or subclones derived from
it. The two oligoprimers were: forward primer (5P) CG (C,G) T
(A,T) CGT (C,G) CC (C,G) T (A,T) CAACGG (3P) and reverse
primer (5P) GT (C,G) CC (C,G) (C,G) C (C,G) CC (C,G) (C,G)
CGTGGTG (3P). The PCR reaction conditions were as follows:
100 ng of template DNA was mixed with 30 pmol of each primer
and 2 U of Taq DNA polymerase (Boehringer) in a total reaction
volume of 100 Wl containing 0.2 mM of each dNTP, 1.5 mM
MgCl2, 2.5% DMSO (Merck) and 10% glycerin. This reaction
mix was overlayed with 50 Wl of mineral oil (Sigma) and the
polymerization reaction was performed in a thermocycler (Miny-
Cycler, MJ Research) under the following conditions: an initial
denaturation of 5 min at 96‡C; 35 cycles of 90 s at 95‡C, 30 s at
60‡C and 90 s at 72‡C; after the 35 cycles, an extra extension step
of 10 min at 72‡C was added, followed by cooling at 4‡C at the
end of this program. The PCR product was used as DNA probe
for Southern hybridization.
4.4. Gene expression
For the expression of elmGT in Streptomyces, the gene was
ampli¢ed by PCR. The following oligoprimers were used: (5P)
ATCGTCTAGAGGCTGCGGGAAGCGACCTGACATG (3P)
for the 5P-end of the gene and (5P) ATCGAAGCTTGTCGCA-
GCGGGCCGTGAGGTCA (3P) for the 3P-end of the gene (re-
striction sites for XbaI and HindIII sites were included in the
oligoprimers, respectively, to facilitate subcloning and are under-
lined). PCR reaction conditions were as follows: 100 ng of tem-
plate DNA was mixed with 30 pmol of each primer and 2 U of
Vent DNA Polymerase (New England Biolabs) in a total reaction
volume of 50 Wl containing 2 mM of each dNTP and 10% DMSO
(Merck). This reaction mix was overlayed with 50 Wl of mineral
oil (Sigma) and the polymerization reaction was performed in a
thermocycler (MinyCycler, MJ Research) under the following
conditions: an initial denaturation of 3 min at 98‡C; 30 cycles
of 30 s at 95‡C, 60 s at 68‡C and 90 s at 72‡C; after the 30 cycles,
an extra extension step of 5 min at 72‡C was added, followed by
cooling at 4‡C at the end of this program. The PCR product was
digested with XbaI and HindIII and subcloned into the same sites
of pUC18. The fragment was then rescued as an XbaI^HindIII
DNA fragment and subcloned into the same sites of pIAGO,
immediately downstream of the erythromycin resistance promoter
(ermEp), generating pGB15. From this construct, a 1.4 kb BglII
fragment, containing both the ermEp and elmGT gene, was res-
cued and subcloned into the unique BamHI site of pKC796,
generating pGB16.
For expression of the di¡erent mithramycin glycosyltransfer-
ases, the following constructs were made: (i) mtmGI : a 2.5 kb
EcoRI^HindIII fragment from pIAGOG1 [12], that contained the
mtmGI gene under the control of the ermEp, was subcloned in the
same sites of pEM4A, generating pEPG1. (ii) mtmGII : a 2.3 kb
EcoRI^HindIII fragment from pIAGOG2 [12], that contained
the mtmGII gene under the control of the ermEp promoter, was
subcloned in the same sites of pEM4A, generating pEPG2.
(iii) mtmGI+mtmGII : a 5.1 kb HindIII^XbaI fragment from
pM12G12 [E. Ferna¤ndez, unpublished results], that contained
the methyltransferase genes mtmMI and mtmMII [13] and the
glycosyltransferase genes mtmGI and mtmGII [12], was subcloned
into the same sites of pEM4A, generating pEPG12. In this con-
struct both glycosyltransferase genes are under the control of
their own promoters.
4.5. Preparation of 8-DMTC
Spores of strain S. argillaceus 16F4 were inoculated in TSB
medium supplemented with 2.5 Wg/ml apramycin. After 24 h of
incubation at 30‡C and 250 rpm, this culture was used to inocu-
late (at 2.5%, v/v) eight 2 l Erlenmeyer £asks containing 400 ml of
R5A medium [7] also containing apramycin. After further incu-
bation for 5 days under the above conditions, the cultures were
centrifuged, ¢ltered and extracted as previously described [7].
8-DMTC was subsequently puri¢ed by reverse-phase preparative
HPLC. The mobile phase used for elution in isocratic conditions
was a mixture of acetonitrile and 0.1% tri£uoroacetic acid in
water (30:70). The peak corresponding to 8-DMTC was col-
lected, dried in vacuo and weighted, resulting in 638 mg of
pure compound as determined by analytical HPLC.
4.6. Biotransformation
For biotransformation experiments, spores of the appropriate
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S. albus recombinant strains were used to inoculate 5 ml of TSB
liquid medium (containing the selection antibiotic) for 24 h at
30‡C and 250 rpm. Then, 100 Wl of this culture was used to
inoculate 5 ml R5A liquid medium. After 24 h of incubation,
8-DMTC was added at 100 Wg/ml ¢nal concentration and the
cultures further incubated. At 24 h intervals, 900 Wl samples
were removed and mixed with 300 Wl ethyl acetate. After centri-
fugation to separate the aqueous and organic phases, the organic
phase was removed, evaporated under vacuo and the residue
resuspended in a small volume of methanol.
4.7. TLC and HPLC analyses
For TLC analysis, 1^2 Wl samples were applied onto pre-coated
silica gel 60 F254 plates and chromatography developed using
dichloromethane/methanol (90/10, v/v) as a solvent. Detection
was carried out by UV light absorption. HPLC analyses of ethyl
acetate extracts were performed as previously described [35].
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